drugset / Trial / NCT04268524
Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan
RandomizedParallel-groupOpen-labelTreatment
Summary
randomised control clinical trial to evaluate miltefosine, thermotherapy and the combination miltefosine-thermotherapy are effective, safe and tolerable alternative treatment options to treat cutaneous leishmaniasis caused by L. tropica, in Pakistan compared to the standard of care.
Timeline
- Start
- 2022-10-07
- Primary completion
- 2025-12-31
- Completion
- 2026-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Miltefosine | Small molecule | 2.5 mg/kg | Oral |
| Subject | Miltefosine | Small molecule | 100 mg | Oral |
| Subject | Miltefosine | Small molecule | 150 mg | Oral |